Ethical problems in clinical psychopharmacology.
The present article originates from some intriguing problems which the author, working as a clinical pharmacologist and psychiatrist, was faced with during clinical investigations. Practical difficulties appearing at first glance as of a rather methodological nature often reveal themselves as ethical questions. Investigation of psychotropic drugs in normal volunteers as well as in psychiatric patients is taken as a model to exemplify certain fundamental ethical aspects of medical research. It is emphasized that the "solution" of ethical problems cannot be achieved by referring to a given code of norms which themselves depend on certain historical circumstances, but rather by recognizing and reasoning the conflicts which result from various moral maxims. Clinical psychopharmacology should not only be conscious of its methodological shortcomings and future goals but also accept the justification of discussions about the ethical and legal questions involved in its dealings and take an active part in these debates. With regard to the relationship between patient and investigator, "solidarity" [23] instead of ongoing paternalism or legal formalism, appears to be a realistic goal. This is also true in the area of psychopharmacological research.
D030881:Disclosure; D004341:Drug Evaluation; D004992:Ethics, Medical; D004994:Ethics, Pharmacy; D005860:Germany, West; D006805:Human Experimentation; D006801:Humans; D028642:Persons with Psychiatric Disorders; D026684:Personal Autonomy; D011600:Psychopharmacology; D011619:Psychotropic Drugs / Q000627:therapeutic use; D012106:Research; D035842:Research Subjects; D035844:Researcher-Subject Relations
D011619:Psychotropic Drugs